{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T09:15:13Z","timestamp":1778145313197,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xkme.2026.101263","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:15:08Z","timestamp":1768320908000},"page":"101263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kidney Failure in Persons With Cystic Fibrosis"],"prefix":"10.1016","volume":"8","author":[{"given":"Mirjana","family":"Stevanovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd A.","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha M.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha L.","family":"Graber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.xkme.2026.101263_bib1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic Fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.xkme.2026.101263_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jcf.2023.02.009","article-title":"Cystic fibrosis prevalence in the United States and participation in the Cystic Fibrosis Foundation Patient Registry in 2020","volume":"22","author":"Cromwell","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.xkme.2026.101263_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"12-13","key":"10.1016\/j.xkme.2026.101263_bib5","first-page":"457","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function","volume":"109","author":"Stanton","year":"1997","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"10.1016\/j.xkme.2026.101263_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12551-014-0140-8","article-title":"CFTR and TNR-CFTR expression and function in the kidney","volume":"6","author":"Souza-Menezes","year":"2014","journal-title":"Biophys Rev"},{"key":"10.1016\/j.xkme.2026.101263_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.742891","article-title":"A developmental role of the cystic fibrosis transmembrane conductance regulator in cystic fibrosis lung disease pathogenesis","volume":"9","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101263_bib8","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1038\/s41598-017-05435-5","article-title":"Defective CFTR leads to aberrant \u03b2-catenin activation and kidney fibrosis","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"issue":"29","key":"10.1016\/j.xkme.2026.101263_bib9","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1074\/jbc.RA118.001846","article-title":"A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector","volume":"293","author":"Yanda","year":"2018","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.xkme.2026.101263_bib10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201105-0932OC","article-title":"Risk factors for chronic kidney disease in adults with cystic fibrosis","volume":"184","author":"Quon","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.xkme.2026.101263_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.jrn.2017.05.006","article-title":"Cystic fibrosis: a risk condition for renal disease","volume":"27","author":"Santoro","year":"2017","journal-title":"J Ren Nutr"},{"issue":"1","key":"10.1016\/j.xkme.2026.101263_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ppul.20138","article-title":"Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use","volume":"39","author":"Al-Aloul","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.xkme.2026.101263_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.702823","article-title":"The potential causes of cystic fibrosis-related diabetes","volume":"12","author":"Coderre","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.xkme.2026.101263_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1681\/ASN.2007080837","article-title":"Acute kidney injury increases risk of ESRD among elderly","volume":"20","author":"Ishani","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2026.101263_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-0636","article-title":"Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry","volume":"161","author":"Mackenzie","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.xkme.2026.101263_bib21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2215\/CJN.06840712","article-title":"The USRDS: what you need to know about what it can and can't tell us about ESRD","volume":"8","author":"Foley","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101263_bib22","first-page":"3","article-title":"CFTR modulator therapies \u2013 effect on life expectancy in people with cystic fibrosis","volume":"42","author":"Balfour-Lynn","year":"2022","journal-title":"Paediatr Respir Rev"},{"issue":"5","key":"10.1016\/j.xkme.2026.101263_bib23","first-page":"4","article-title":"Racial disparities in chronic kidney diseases in the United States: a pressing public health challenge with social, behavioral and medical causes.","volume":"201i","author":"Assari","year":"2014","journal-title":"J Nephropharmacol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101263_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcf.2022.07.010","article-title":"Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening","volume":"22","author":"McColley","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"Suppl 2","key":"10.1016\/j.xkme.2026.101263_bib25","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcf.2019.08.003","article-title":"Cystic fibrosis related diabetes: medical management","volume":"18","author":"Ode","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.xkme.2026.101263_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268805","article-title":"Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997\u20132018","volume":"17","author":"Koyama","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.xkme.2026.101263_bib27","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1210\/clinem\/dgac020","article-title":"New concepts in the pathogenesis of cystic fibrosis\u2013related diabetes","volume":"107","author":"Moheet","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xkme.2026.101263_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820966428","article-title":"Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes","volume":"11","author":"Kempegowda","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.xkme.2026.101263_bib29","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.xkme.2026.101263_bib30","first-page":"314","article-title":"The association of diabetes with all-cause mortality in patients with end-stage renal disease compared to the general population in Poland: a comparative analysis","volume":"18","author":"Wierzba","year":"2022","journal-title":"Arch Med Sci"},{"issue":"6","key":"10.1016\/j.xkme.2026.101263_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.healun.2020.02.010","article-title":"Lung transplantation for cystic fibrosis","volume":"39","author":"Yeung","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.xkme.2026.101263_bib32","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/jcm8101713","article-title":"Acute kidney injury after lung transplantation: a systematic review and meta-analysis","volume":"8","author":"Lertjitbanjong","year":"2019","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.xkme.2026.101263_bib33","article-title":"Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss","volume":"69","author":"Broekroelofs","year":"2000","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.xkme.2026.101263_bib34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJM198808043190502","article-title":"Microscopic nephrocalcinosis in cystic fibrosis","volume":"319","author":"Katz","year":"1988","journal-title":"N Engl Med"},{"issue":"4","key":"10.1016\/j.xkme.2026.101263_bib35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MNH.0000000000000725","article-title":"Cystic fibrosis in the kidney: new lessons from impaired renal HCO3-excretion","volume":"30","author":"Berg","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"10.1016\/j.xkme.2026.101263_bib36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1542-4758.2012.00675.x","article-title":"Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis","volume":"16","author":"Florescu","year":"2012","journal-title":"Hemodial Int"},{"key":"10.1016\/j.xkme.2026.101263_bib37","article-title":"Outcomes of kidney transplantation in cystic fibrosis","author":"Stevanovic","year":"2024","journal-title":"medRxiv"},{"issue":"4","key":"10.1016\/j.xkme.2026.101263_bib38","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2026.101263_bib39","first-page":"1315","article-title":"Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation","volume":"12","author":"Hostetter","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101263_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/2054358119899312","article-title":"Estimation of GFR in patients with cystic fibrosis: a cross-sectional study","volume":"7","author":"Wallace","year":"2020","journal-title":"Can J Kidney Health Dis"},{"issue":"1","key":"10.1016\/j.xkme.2026.101263_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcf.2006.05.004","article-title":"Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients","volume":"6","author":"Al-Aloul","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.xkme.2026.101263_bib42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jcf.2024.12.007","article-title":"Lung-kidney axis in cystic fibrosis: early urinary markers of kidney injury correlate with neutrophil activation and worse lung function","volume":"24","author":"Rosner","year":"2025","journal-title":"J Cyst Fibros"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:40:23Z","timestamp":1778143223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2590059526000245"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101263","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney Failure in Persons With Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101263"}}